These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21274701)

  • 21. Comparative effects of the alpha7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice.
    Marighetto A; Valerio S; Desmedt A; Philippin JN; Trocmé-Thibierge C; Morain P
    Psychopharmacology (Berl); 2008 Apr; 197(3):499-508. PubMed ID: 18265960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memantine in the treatment of mild-to-moderate Alzheimer's disease.
    Cosman KM; Boyle LL; Porsteinsson AP
    Expert Opin Pharmacother; 2007 Feb; 8(2):203-14. PubMed ID: 17257090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests.
    Lainiola M; Procaccini C; Linden AM
    Behav Brain Res; 2014 Jun; 266():94-103. PubMed ID: 24631392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.
    Bernard K; Danober L; Thomas JY; Lebrun C; Muñoz C; Cordi A; Desos P; Lestage P; Morain P
    CNS Neurosci Ther; 2010 Oct; 16(5):e193-212. PubMed ID: 21050420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the uncompetitive NMDA receptor antagonist memantine on spatial memory in medial septal lesioned rats.
    Dashniani M; Burjanadze M; Beselia G; Chkhikvishvili N; Kruashvili L
    Georgian Med News; 2011 Dec; (201):55-61. PubMed ID: 22306503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat.
    Rosi S; Vazdarjanova A; Ramirez-Amaya V; Worley PF; Barnes CA; Wenk GL
    Neuroscience; 2006 Nov; 142(4):1303-15. PubMed ID: 16989956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative protective action of curcumin, memantine and diclofenac against scopolamine-induced memory dysfunction.
    Ali EH; Arafa NM
    Fitoterapia; 2011 Jun; 82(4):601-8. PubMed ID: 21277954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.
    Kumar H; Sharma B
    Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intra-accumbens NMDA and AMPA receptor antagonists on short-term spatial learning in the Morris water maze task.
    Ferretti V; Sargolini F; Oliverio A; Mele A; Roullet P
    Behav Brain Res; 2007 Apr; 179(1):43-9. PubMed ID: 17289166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of memantine for elderly patients in the mild stage of Alzheimer's and vascular dementia].
    Bachyns'ka NIu; Rozheliuk IF; Polietaieva KM; Kholin VO
    Lik Sprava; 2013; (7):80-96. PubMed ID: 25509921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of contextual memory by S 24795 in aged mice: comparison with memantine.
    Beracochea D; Boucard A; Trocme-Thibierge C; Morain P
    Psychopharmacology (Berl); 2008 Mar; 196(4):555-64. PubMed ID: 18034231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Memantine for dementia.
    Areosa Sastre A; McShane R; Sherriff F
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003154. PubMed ID: 15495043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA; Wenk GL
    CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.
    Parsons CG; Stöffler A; Danysz W
    Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
    Zhu G; Li J; He L; Wang X; Hong X
    Br J Pharmacol; 2015 May; 172(9):2354-68. PubMed ID: 25560396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
    Majláth Z; Török N; Toldi J; Vécsei L
    Curr Neuropharmacol; 2016; 14(2):200-9. PubMed ID: 26564141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test.
    Costa AC; Scott-McKean JJ; Stasko MR
    Neuropsychopharmacology; 2008 Jun; 33(7):1624-32. PubMed ID: 17700645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial.
    Yang JC; Rodriguez A; Royston A; Niu YQ; Avar M; Brill R; Simon C; Grigsby J; Hagerman RJ; Olichney JM
    Sci Rep; 2016 Feb; 6():21719. PubMed ID: 26898832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mGluR
    Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
    J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.